Melinta Therapeutics, Inc.: Chapter 11 case summary
ElevenFlo ·
Melinta’s December 27, 2019 Chapter 11 proceeding ended in a confirmed reorganization plan and a final decree closing the cases Dkt. 8, signed June 30, 2021. The plan was effective by April 20, 2020, and the confirmation order was affirmed on appeal in March 2021.
Melinta Therapeutics’ December 27, 2019 Chapter 11 proceeding concluded with a final decree closing the cases Dkt. 8, signed June 30, 2021. The debtors reported that their modified amended reorganization plan had been confirmed and had become effective in an April 20, 2020 notice Dkt. 542. The confirmation order was affirmed on appeal Dkt. 915 on March 16, 2021.
At the petition date, the antibiotic developer and its debtor affiliates had approximately $213.3 million in outstanding principal of long-term funded debt, according to the first-day declaration Dkt. 17. That comprised approximately $133.3 million of senior secured Deerfield loans and $80 million of subordinated convertible Vatera loans. During the case, the court entered a final cash collateral order Dkt. 279 and approved bidding procedures Dkt. 280 before the reorganization plan became effective.
Sources
- Dkt. 8Final Decree and Order Closing Chapter 11 Cases Signed on 6/30/2021 (LB)Filed Jul 13, 2021Jul 13, 2021
- Dkt. 17Declaration of Peter Milligan in Support of Chapter 11 Petitions and First-Day Papers (Filed by Melinta Therapeutics, Inc.)Filed Dec 27, 2019Dec 27, 2019
- Dkt. 279Final Order (I) Authorizing the Use of Cash Collateral; (II) Granting Adequate Protection; (III) Modifying Automatic Stay; and (IV) Granting Related ReliefFiled Feb 11, 2020Feb 11, 2020
- Dkt. 280Order (A) Establishing Bidding Procedures; (B) Approving Expense Reimbursement; (C) Establishing Procedures Relating to the Assumption or Assumption and Assignment of Certain Executory Contracts and Unexpired Leases, Including Notice of Proposed Cure Amounts; (D) Approving Form and Manner of Notice of All Procedures, Protections, Schedules, and Agreements; (E) Scheduling a Hearing to Consider Any Proposed Sale; and (F) Granting Certain Related ReliefFiled Feb 11, 2020Feb 11, 2020
- Dkt. 542Notice of (I) Entry of Findings of Fact, Conclusions of Law and Order Confirming Modified Amended Joint Plan of Reorganization of Melinta Therapeutics, Inc. and its Debtor Affiliates and (II) Occurrence of Effective Date (Filed by Melinta Therapeutics, Inc.)Filed Apr 20, 2020Apr 20, 2020
- Dkt. 915Order on 1) the Confirmation Order (Bankr. D.I. 520) is Affirmed; and 2) the Clerk of the Court is Directed to Close C.A. No. 20-600-MNFiled Mar 16, 2021Mar 16, 2021